Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.

Leach, Amanda Jane; Mulholland, Edward Kim; Santosham, Mathuram; Torzillo, Paul John; McIntyre, Peter; Smith-Vaughan, Heidi; Wilson, Nicole; Arrowsmith, Beth; Beissbarth, Jemima; Chatfield, Mark D; +8 more... Oguoma, Victor M; Licciardi, Paul; Skull, Sue; Andrews, Ross; Carapetis, Jonathan; McDonnell, Joseph; Krause, Vicki; Morris, Peter Stanley; (2021) Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial. Vaccine: X, 7. 100086-. ISSN 2590-1362 DOI: https://doi.org/10.1016/j.jvacx.2021.100086

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jvacx.2021.100086

Abstract

Share

Download

Filename: Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal iHaemophilus influenzaei protein D conjug.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar